You are here

Article metrics

Article menu

Download PDFPDF

Migraine
Research paper
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis

 

Online download statistics by month:

Online download statistics by month: April 2019 to March 2024

AbstractFullPdf
Apr 2019570564183
May 2019535526112
Jun 201928528463
Jul 2019487485104
Aug 201923723789
Sep 201914514537
Oct 201915215132
Nov 201913413341
Dec 201912412339
Jan 202010210227
Feb 2020828223
Mar 2020848427
Apr 2020555429
May 2020585821
Jun 2020424121
Jul 2020464633
Aug 2020333430
Sep 2020524633
Oct 2020696520
Nov 2020676442
Dec 2020524729
Jan 2021585435
Feb 2021696319
Mar 2021615925
Apr 2021646329
May 2021605729
Jun 2021534824
Jul 2021535317
Aug 2021696223
Sep 2021837622
Oct 202110210345
Nov 2021726838
Dec 2021616011
Jan 2022899225
Feb 202210810826
Mar 202210710232
Apr 202210710526
May 202210310621
Jun 2022706822
Jul 2022767213
Aug 2022747113
Sep 202211011236
Oct 202210810923
Nov 2022929218
Dec 202252549
Jan 2023454720
Feb 2023938920
Mar 2023707117
Apr 2023312910
May 2023717027
Jun 2023585716
Jul 2023444316
Aug 2023747413
Sep 2023485110
Oct 202310410918
Nov 2023889022
Dec 2023514812
Jan 2024444219
Feb 2024444411
Mar 2024696947
Total624661611894